Note: ADME is also used to delineate these selected parameters within the context of a xenobiotic’s pharmacokinetic profile. Because any of the five characteristics may become hurdles during drug development, ADMET behaviour is typically studied and optimized among efficacious analogues during the early drug discovery stage by using in vitro models that attempt to predict such behaviours in clinical studies.